Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Philippe L. Bedard
Based on 31 articles published since 2009
(Why 31 articles?)
||||
Expertise Level
The expertise of Philippe L. Bedard ranks in the
  • Top 0.09%
  • ... of 263,954 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 31 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Aliases Bedard, P   ·   Bedard, Philippe L   ·   Bedard, Philippe   ·   Bedard, P L
Work Locations
Details
Most likely:    University Health Network of Toronto      
2018
  • From the University of Wisconsin Carbone Cancer Center, Madison, WI; Department of Medicine, Division of Hematology/Oncology, University of Wisconsin, Madison, WI; Yale Cancer Center, New Haven, CT; Princess Margaret Hospital, Calgary, ON, Canada; Princess Margaret Cancer Center, Toronto, ON, Canada. · Pubmed 30231387
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 7-723 700 University Avenue, Toronto, Canada. · Department of Medicine, University of Toronto, Toronto, Canada. · Division of Medical Oncology and Hematology, Sunnybrook Odette Cancer Centre, Toronto, Canada. · Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan. · Laboratory Medicine Program, University Health Network, Toronto, Canada. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada. · Cancer Genomics Program, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Medical Biophysics, University of Toronto, Toronto, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 7-723 700 University Avenue, Toronto, Canada. · Department of Medicine, University of Toronto, Toronto, Canada. · Cancer Genomics Program, Princess Margaret Cancer Centre, Toronto, Canada. · Pubmed 29177603
2017
  • Division of Medical Oncology & Hematology, Department of Medicine, University of Toronto & Princess Margaret Cancer Centre, Toronto, ON,  M5G 1Z9, Canada. · Pubmed 29168649
  • Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA. · Princess Margaret Cancer Centre, Toronto, ON, Canada. · Seoul National University College of Medicine, Seoul, Republic of Korea. · National Taiwan University Hospital, Taipei, Taiwan. · Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain. · Moores Cancer Center, University of California at San Diego, La Jolla, CA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Huntsman Cancer Institute, Salt Lake City, UT, USA. · Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA. · University of Chicago, Chicago, IL, USA. · City of Hope, Department of Medical Oncology and Therapeutics Research, Duarte, CA, USA. · Novartis Pharma AG, Basel, Switzerland. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Pfizer Inc., New York, NY, USA. · Novartis Institutes for BioMedical Research, Cambridge, MA, USA. · Pubmed 28899363
  • Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri. · Division of Public Health Science, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri. · Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medicine, Stanford University School of Medicine, Stanford, California. · Department of Medicine, Duke Cancer Institute, Durham, North Carolina. · Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri. · Medical Oncology, Mayo Clinic, Rochester, Minnesota. · Medical Oncology, University of Southern California, Los Angeles, California. · Medical Oncology, Rush University Medical Center, Chicago, Illinois. · Department of Medicine, University of Alabama Birmingham, Birmingham, Alabama. · Department of Oncology-Hematology, St. Luke's Cancer Institute, Kansas City, Missouri. · Department of Medicine, University of North Carolina, Chapel Hill, North Carolina. · Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas. · Guardant Health Inc., Redwood City, California. · Puma Biotechnology, Los Angeles, California. · Genomic and Pathology Service, Washington University School of Medicine, St. Louis, Missouri. · Department of Hematology and Oncology, University of Michigan, Ann Arbor, Michigan. · Department of Medicine, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California. · Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas. · Pubmed 28679771
2016
  • National Cancer Institute of Mexico, Mexico City, Mexico. · Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada. · Princess Margaret Hospital, Toronto, Ontario, Canada. · Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada · Pubmed 24888812
  • Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. · Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. · Department of Genetics, Norris Cotton Cancer Center, Dartmouth Medical School, Lebanon, New Hampshire, USA. · Department of Genetics, Stanford University School of Medicine, Stanford, California, USA. · Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. · Department of Computer Science, University of Toronto, Toronto, Ontario, Canada. · Division of Medical Oncology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada. · Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts, USA. · Ontario Institute for Cancer Research, Toronto, Ontario, Canada. · Pubmed 27571262
  • Laboratory Medicine Program, Advanced Molecular Diagnostics Laboratory, Department of Pathology, University Health Network, Toronto, Ontario, Canada. · Cancer Genomics Program, Princess Margaret Cancer Centre, The University Health Network, Toronto, Ontario, Canada. · Division of Medical Oncology, Princess Margaret Cancer Centre, The University Health Network, Toronto, Ontario, Canada. · Department of Laboratory Medicine and Pathobiology, The University of Toronto, Toronto, Ontario, Canada. · Pubmed 25880439
2015
  • Princess Margaret Cancer Centre, University Health Network, University of Toronto, and Campbell Family Institute for Breast Cancer Research, Toronto, Ontario, Canada. · Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada · Pubmed 25559805
  • Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada. · Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Pubmed 26076967
  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada. · The Campbell Family Institute for Breast Cancer Research at the Princess Margaret Cancer Centre, Toronto, Canada. · Department of Biochemistry and Medical Genetics, George and Fay Yee Centre for Healthcare Innovation, University of Manitoba, Winnipeg, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada. · Division of Medical Oncology, The Ottawa Hospital Cancer Center, Ottawa, Canada. · Division of General Surgery and Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Department of Medical Biophysics, University of Toronto, Toronto, Canada. · Laboratory Medicine Program, University Health Network, Toronto, Canada. · Pubmed 25529931
2014
  • Affiliations of authors: Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada (FEV-B, AJT, PdG, ID-P, PLB, MA-M, IFT, AO, EA) · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia (BS) · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain (AO). · Pubmed 24273215
2011
  • Division of Medical Oncology, Princess Margaret Hospital, Toronto, ON M5G 2M9, Canada. · Pubmed 21364525
  • Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Hospital, University of Toronto, Ontario, Canada. · Pubmed 21984694
2017
  • From the University of Utah, Salt Lake City, UT; Department of Medicine, Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. · Pubmed 28561710
2015
  • Bras Drug Development Program, Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, 5-125, 610 University Avenue, Toronto, ON M5G 2M9, Canada. · Pubmed 25893859
2013
  • aDrug Development Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre bDepartment of Medicine, University of Toronto, Toronto, Ontario, Canada. · Pubmed 24097103
  • Princess Margaret Hospital, Toronto, ON M5G 2M9, Canada. · Pubmed 23868004
2012
  • Division of Medical Oncology and Hematology, Princess Margaret Hospital, 610 University Ave 5-124, Toronto, ON M5G 2M9, Canada. · Pubmed 22988040
  • Division of Medical Oncology and Hematology, Princess Margaret Hospital, Department of Medicine, University of Toronto, 610 University Avenue, Toronto, Ontario, Canada. · Pubmed 22956007
2011
  • Princess Margaret Hospital, 610 University Avenue, Toronto, Canada. · Pubmed 22217398
  • Radiation Medicine Program, Princess Margaret Hospital, University Health Network, 610 University Avenue, Toronto M5G2M9, Ontario, Canada. · Pubmed 22024340
Probable:    University of Toronto   Contact    
2018
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 7-723 700 University Avenue, Toronto, Canada. · Department of Medicine, University of Toronto, Toronto, Canada. · Division of Medical Oncology and Hematology, Sunnybrook Odette Cancer Centre, Toronto, Canada. · Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan. · Laboratory Medicine Program, University Health Network, Toronto, Canada. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada. · Cancer Genomics Program, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Medical Biophysics, University of Toronto, Toronto, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 7-723 700 University Avenue, Toronto, Canada. · Department of Medicine, University of Toronto, Toronto, Canada. · Cancer Genomics Program, Princess Margaret Cancer Centre, Toronto, Canada. · Pubmed 29177603
2017
  • Division of Medical Oncology & Hematology, Department of Medicine, University of Toronto & Princess Margaret Cancer Centre, Toronto, ON,  M5G 1Z9, Canada. · Pubmed 29168649
2016
  • Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. · Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. · Department of Genetics, Norris Cotton Cancer Center, Dartmouth Medical School, Lebanon, New Hampshire, USA. · Department of Genetics, Stanford University School of Medicine, Stanford, California, USA. · Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. · Department of Computer Science, University of Toronto, Toronto, Ontario, Canada. · Division of Medical Oncology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada. · Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts, USA. · Ontario Institute for Cancer Research, Toronto, Ontario, Canada. · Pubmed 27571262
  • Mark N. Levine, Jim A. Julian, and Louise Bordeleau, McMaster University, Hamilton · Mark N. Levine and Louise Bordeleau, Hamilton Health Sciences Juravinski Cancer Centre, Hamilton · Mark N. Levine and Jim A. Julian, Ontario Clinical Oncology Group and Escarpment Cancer Research Institute, Hamilton · Philippe L. Bedard, Andrea Eisen, Maureen E. Trudeau, and Kathleen I. Pritchard, University of Toronto, Toronto · Phillipe L. Bedard, Princess Margaret Hospital, Toronto · Andrea Eisen, Maureen E. Trudeau, and Kathleen I. Pritchard, Odette Sunnybrook Regional Cancer Centre · Toronto · and Brian Higgins, Peel Regional Cancer Centre, Mississauga, Ontario, Canada. · Pubmed 26598746
2015
  • Princess Margaret Cancer Centre, University Health Network, University of Toronto, and Campbell Family Institute for Breast Cancer Research, Toronto, Ontario, Canada. · Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada · Pubmed 25559805
  • Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada. · Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Pubmed 26076967
2014
  • Affiliations of authors: Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada (FEV-B, AJT, PdG, ID-P, PLB, MA-M, IFT, AO, EA) · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia (BS) · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain (AO). · Pubmed 24273215
2011
  • Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Hospital, University of Toronto, Ontario, Canada. · Pubmed 21984694
2017
  • From the University of Utah, Salt Lake City, UT; Department of Medicine, Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. · Pubmed 28561710
2013
  • aDrug Development Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre bDepartment of Medicine, University of Toronto, Toronto, Ontario, Canada. · Pubmed 24097103
  • Toronto Health Economics and Technology Assessment (THETA) Collaborative, University of Toronto, Toronto, ON, Canada. · Pubmed 23947965
2012
  • Division of Medical Oncology and Hematology, Princess Margaret Hospital, Department of Medicine, University of Toronto, 610 University Avenue, Toronto, Ontario, Canada. · Pubmed 22956007
Probable:    University of Wisconsin   Contact    
2018
  • From the University of Wisconsin Carbone Cancer Center, Madison, WI; Department of Medicine, Division of Hematology/Oncology, University of Wisconsin, Madison, WI; Yale Cancer Center, New Haven, CT; Princess Margaret Hospital, Calgary, ON, Canada; Princess Margaret Cancer Center, Toronto, ON, Canada. · Pubmed 30231387
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 31 total) written by Philippe L. Bedard about Breast Neoplasms:

  • Incorporating Genomics Into the Care of Patients With Advanced Breast Cancer. 2018
  • Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer. 2018
  • Utility of molecular tools for extended adjuvant endocrine therapy decisions in early breast cancer. 2017
  • Standard and Genomic Tools for Decision Support in Breast Cancer Treatment. 2017
  • A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer. 2017
  • Neratinib Efficacy and Circulating Tumor DNA Detection of 2017
  • Complete Response of Metastatic Androgen Receptor-Positive Breast Cancer to Bicalutamide: Case Report and Review of the Literature. 2016
  • Noncoding somatic and inherited single-nucleotide variants converge to promote ESR1 expression in breast cancer. 2016
  • Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario. 2016
  • A classification system for clinical relevance of somatic variants identified in molecular profiling of cancer. 2016
Show List of Full Article Records
Google Searches

Learn more about Philippe L. Bedard using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University Health Network of Toronto
University of Toronto
University of Wisconsin
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University Health Network of Toronto
2018
  • From the University of Wisconsin Carbone Cancer Center, Madison, WI; Department of Medicine, Division of Hematology/Oncology, University of Wisconsin, Madison, WI; Yale Cancer Center, New Haven, CT; Princess Margaret Hospital, Calgary, ON, Canada; Princess Margaret Cancer Center, Toronto, ON, Canada. · Pubmed 30231387
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 7-723 700 University Avenue, Toronto, Canada. · Department of Medicine, University of Toronto, Toronto, Canada. · Division of Medical Oncology and Hematology, Sunnybrook Odette Cancer Centre, Toronto, Canada. · Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan. · Laboratory Medicine Program, University Health Network, Toronto, Canada. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada. · Cancer Genomics Program, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Medical Biophysics, University of Toronto, Toronto, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 7-723 700 University Avenue, Toronto, Canada. · Department of Medicine, University of Toronto, Toronto, Canada. · Cancer Genomics Program, Princess Margaret Cancer Centre, Toronto, Canada. · Pubmed 29177603
2017
  • Division of Medical Oncology & Hematology, Department of Medicine, University of Toronto & Princess Margaret Cancer Centre, Toronto, ON,  M5G 1Z9, Canada. · Pubmed 29168649
  • Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA. · Princess Margaret Cancer Centre, Toronto, ON, Canada. · Seoul National University College of Medicine, Seoul, Republic of Korea. · National Taiwan University Hospital, Taipei, Taiwan. · Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain. · Moores Cancer Center, University of California at San Diego, La Jolla, CA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Huntsman Cancer Institute, Salt Lake City, UT, USA. · Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA. · University of Chicago, Chicago, IL, USA. · City of Hope, Department of Medical Oncology and Therapeutics Research, Duarte, CA, USA. · Novartis Pharma AG, Basel, Switzerland. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Pfizer Inc., New York, NY, USA. · Novartis Institutes for BioMedical Research, Cambridge, MA, USA. · Pubmed 28899363
  • Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri. · Division of Public Health Science, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri. · Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medicine, Stanford University School of Medicine, Stanford, California. · Department of Medicine, Duke Cancer Institute, Durham, North Carolina. · Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri. · Medical Oncology, Mayo Clinic, Rochester, Minnesota. · Medical Oncology, University of Southern California, Los Angeles, California. · Medical Oncology, Rush University Medical Center, Chicago, Illinois. · Department of Medicine, University of Alabama Birmingham, Birmingham, Alabama. · Department of Oncology-Hematology, St. Luke's Cancer Institute, Kansas City, Missouri. · Department of Medicine, University of North Carolina, Chapel Hill, North Carolina. · Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas. · Guardant Health Inc., Redwood City, California. · Puma Biotechnology, Los Angeles, California. · Genomic and Pathology Service, Washington University School of Medicine, St. Louis, Missouri. · Department of Hematology and Oncology, University of Michigan, Ann Arbor, Michigan. · Department of Medicine, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California. · Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas. · Pubmed 28679771
2016
  • National Cancer Institute of Mexico, Mexico City, Mexico. · Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada. · Princess Margaret Hospital, Toronto, Ontario, Canada. · Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada · Pubmed 24888812
  • Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. · Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. · Department of Genetics, Norris Cotton Cancer Center, Dartmouth Medical School, Lebanon, New Hampshire, USA. · Department of Genetics, Stanford University School of Medicine, Stanford, California, USA. · Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. · Department of Computer Science, University of Toronto, Toronto, Ontario, Canada. · Division of Medical Oncology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada. · Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts, USA. · Ontario Institute for Cancer Research, Toronto, Ontario, Canada. · Pubmed 27571262
  • Laboratory Medicine Program, Advanced Molecular Diagnostics Laboratory, Department of Pathology, University Health Network, Toronto, Ontario, Canada. · Cancer Genomics Program, Princess Margaret Cancer Centre, The University Health Network, Toronto, Ontario, Canada. · Division of Medical Oncology, Princess Margaret Cancer Centre, The University Health Network, Toronto, Ontario, Canada. · Department of Laboratory Medicine and Pathobiology, The University of Toronto, Toronto, Ontario, Canada. · Pubmed 25880439
2015
  • Princess Margaret Cancer Centre, University Health Network, University of Toronto, and Campbell Family Institute for Breast Cancer Research, Toronto, Ontario, Canada. · Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada · Pubmed 25559805
  • Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada. · Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Pubmed 26076967
  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada. · The Campbell Family Institute for Breast Cancer Research at the Princess Margaret Cancer Centre, Toronto, Canada. · Department of Biochemistry and Medical Genetics, George and Fay Yee Centre for Healthcare Innovation, University of Manitoba, Winnipeg, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada. · Division of Medical Oncology, The Ottawa Hospital Cancer Center, Ottawa, Canada. · Division of General Surgery and Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Department of Medical Biophysics, University of Toronto, Toronto, Canada. · Laboratory Medicine Program, University Health Network, Toronto, Canada. · Pubmed 25529931
2014
  • Affiliations of authors: Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada (FEV-B, AJT, PdG, ID-P, PLB, MA-M, IFT, AO, EA) · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia (BS) · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain (AO). · Pubmed 24273215
2011
  • Division of Medical Oncology, Princess Margaret Hospital, Toronto, ON M5G 2M9, Canada. · Pubmed 21364525
  • Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Hospital, University of Toronto, Ontario, Canada. · Pubmed 21984694
2017
  • From the University of Utah, Salt Lake City, UT; Department of Medicine, Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. · Pubmed 28561710
2015
  • Bras Drug Development Program, Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, 5-125, 610 University Avenue, Toronto, ON M5G 2M9, Canada. · Pubmed 25893859
2013
  • aDrug Development Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre bDepartment of Medicine, University of Toronto, Toronto, Ontario, Canada. · Pubmed 24097103
  • Princess Margaret Hospital, Toronto, ON M5G 2M9, Canada. · Pubmed 23868004
2012
  • Division of Medical Oncology and Hematology, Princess Margaret Hospital, 610 University Ave 5-124, Toronto, ON M5G 2M9, Canada. · Pubmed 22988040
  • Division of Medical Oncology and Hematology, Princess Margaret Hospital, Department of Medicine, University of Toronto, 610 University Avenue, Toronto, Ontario, Canada. · Pubmed 22956007
2011
  • Princess Margaret Hospital, 610 University Avenue, Toronto, Canada. · Pubmed 22217398
  • Radiation Medicine Program, Princess Margaret Hospital, University Health Network, 610 University Avenue, Toronto M5G2M9, Ontario, Canada. · Pubmed 22024340
University of Toronto
2018
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 7-723 700 University Avenue, Toronto, Canada. · Department of Medicine, University of Toronto, Toronto, Canada. · Division of Medical Oncology and Hematology, Sunnybrook Odette Cancer Centre, Toronto, Canada. · Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan. · Laboratory Medicine Program, University Health Network, Toronto, Canada. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada. · Cancer Genomics Program, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Medical Biophysics, University of Toronto, Toronto, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 7-723 700 University Avenue, Toronto, Canada. · Department of Medicine, University of Toronto, Toronto, Canada. · Cancer Genomics Program, Princess Margaret Cancer Centre, Toronto, Canada. · Pubmed 29177603
2017
  • Division of Medical Oncology & Hematology, Department of Medicine, University of Toronto & Princess Margaret Cancer Centre, Toronto, ON,  M5G 1Z9, Canada. · Pubmed 29168649
2016
  • Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. · Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. · Department of Genetics, Norris Cotton Cancer Center, Dartmouth Medical School, Lebanon, New Hampshire, USA. · Department of Genetics, Stanford University School of Medicine, Stanford, California, USA. · Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. · Department of Computer Science, University of Toronto, Toronto, Ontario, Canada. · Division of Medical Oncology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada. · Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts, USA. · Ontario Institute for Cancer Research, Toronto, Ontario, Canada. · Pubmed 27571262
  • Mark N. Levine, Jim A. Julian, and Louise Bordeleau, McMaster University, Hamilton · Mark N. Levine and Louise Bordeleau, Hamilton Health Sciences Juravinski Cancer Centre, Hamilton · Mark N. Levine and Jim A. Julian, Ontario Clinical Oncology Group and Escarpment Cancer Research Institute, Hamilton · Philippe L. Bedard, Andrea Eisen, Maureen E. Trudeau, and Kathleen I. Pritchard, University of Toronto, Toronto · Phillipe L. Bedard, Princess Margaret Hospital, Toronto · Andrea Eisen, Maureen E. Trudeau, and Kathleen I. Pritchard, Odette Sunnybrook Regional Cancer Centre · Toronto · and Brian Higgins, Peel Regional Cancer Centre, Mississauga, Ontario, Canada. · Pubmed 26598746
2015
  • Princess Margaret Cancer Centre, University Health Network, University of Toronto, and Campbell Family Institute for Breast Cancer Research, Toronto, Ontario, Canada. · Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada · Pubmed 25559805
  • Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada. · Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Pubmed 26076967
2014
  • Affiliations of authors: Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada (FEV-B, AJT, PdG, ID-P, PLB, MA-M, IFT, AO, EA) · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia (BS) · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain (AO). · Pubmed 24273215
2011
  • Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Hospital, University of Toronto, Ontario, Canada. · Pubmed 21984694
2017
  • From the University of Utah, Salt Lake City, UT; Department of Medicine, Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. · Pubmed 28561710
2013
  • aDrug Development Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre bDepartment of Medicine, University of Toronto, Toronto, Ontario, Canada. · Pubmed 24097103
  • Toronto Health Economics and Technology Assessment (THETA) Collaborative, University of Toronto, Toronto, ON, Canada. · Pubmed 23947965
2012
  • Division of Medical Oncology and Hematology, Princess Margaret Hospital, Department of Medicine, University of Toronto, 610 University Avenue, Toronto, Ontario, Canada. · Pubmed 22956007
University of Wisconsin
2018
  • From the University of Wisconsin Carbone Cancer Center, Madison, WI; Department of Medicine, Division of Hematology/Oncology, University of Wisconsin, Madison, WI; Yale Cancer Center, New Haven, CT; Princess Margaret Hospital, Calgary, ON, Canada; Princess Margaret Cancer Center, Toronto, ON, Canada. · Pubmed 30231387
Yale University
2018
  • From the University of Wisconsin Carbone Cancer Center, Madison, WI; Department of Medicine, Division of Hematology/Oncology, University of Wisconsin, Madison, WI; Yale Cancer Center, New Haven, CT; Princess Margaret Hospital, Calgary, ON, Canada; Princess Margaret Cancer Center, Toronto, ON, Canada. · Pubmed 30231387
6 Other Locations Show
Yearly article counts 02444144620
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.